118 related articles for article (PubMed ID: 37722165)
1. Simultaneous quantification of atorvastatin, erlotinib and OSI-420 in rat serum and liver microsomes using a novel liquid chromatography-mass spectrometry method.
Rysz MA; Kinzi J; Schäfer AM; In-Albon K; Zürcher S; Schmidlin S; Seibert I; Schwardt O; Ricklin D; Meyer Zu Schwabedissen HE
J Pharm Biomed Anal; 2023 Nov; 236():115716. PubMed ID: 37722165
[TBL] [Abstract][Full Text] [Related]
2. A validated liquid chromatography tandem mass spectrometry method for quantification of erlotinib, OSI-420 and didesmethyl erlotinib and semi-quantification of erlotinib metabolites in human plasma.
Svedberg A; Gréen H; Vikström A; Lundeberg J; Vikingsson S
J Pharm Biomed Anal; 2015 Mar; 107():186-95. PubMed ID: 25594896
[TBL] [Abstract][Full Text] [Related]
3. Humanization of
Rysz M; Schäfer AM; Paloumpis N; Kinzi J; Brecht K; Seibert I; Schmidlin S; In-Albon K; Ricklin D; Meyer Zu Schwabedissen HE
J Pharmacol Exp Ther; 2024 Mar; 389(1):87-95. PubMed ID: 38448247
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of erlotinib and its isomeric major metabolites in human plasma using isocratic liquid chromatography-tandem mass spectrometry and its clinical application.
Ishida T; Naito T; Kawakami J
Biomed Chromatogr; 2015 May; 29(5):643-6. PubMed ID: 25296722
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation.
Thappali SR; Varanasi K; Veeraraghavan S; Arla R; Chennupati S; Rajamanickam M; Vakkalanka S; Khagga M
Sci Pharm; 2012; 80(3):633-46. PubMed ID: 23008811
[TBL] [Abstract][Full Text] [Related]
6. The quantification of erlotinib (OSI-774) and OSI-420 in human plasma by liquid chromatography-tandem mass spectrometry.
Masters AR; Sweeney CJ; Jones DR
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):379-83. PubMed ID: 17101305
[TBL] [Abstract][Full Text] [Related]
7. Rapid high performance liquid chromatography method for erlotinib quantification in vitro: Application to study the effect of resveratrol on metabolism and cellular uptake of erlotinib.
Zayed A; Al Hroot J; Mayyas A; Al-Husein B
Fundam Clin Pharmacol; 2023 Oct; 37(5):983-993. PubMed ID: 37143385
[TBL] [Abstract][Full Text] [Related]
8. Bioanalysis of erlotinib, its O-demethylated metabolites OSI-413 and OSI-420, and other metabolites by liquid chromatography-tandem mass spectrometry with additional ion mobility identification.
Rood JJM; Toraño JS; Somovilla VJ; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1166():122554. PubMed ID: 33540147
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of erlotinib and tamoxifen in rat plasma using UPLC-MS/MS: Application to pharmacokinetic interaction studies.
Maher HM; Alzoman NZ; Shehata SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():100-110. PubMed ID: 27336702
[TBL] [Abstract][Full Text] [Related]
10. High-Throughput Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry Method Validation for the Estimation of Atorvastatin and Active Metabolites in Human Plasma.
Agrawal N; Mittal A
Assay Drug Dev Technol; 2023 Apr; 21(3):110-125. PubMed ID: 37036476
[TBL] [Abstract][Full Text] [Related]
11. High-throughput LC-MS/MS Method for Simultaneous Determination of Pantoprazole and Atorvastatin in Rat Plasma: Application to a Pharmacokinetic Interaction Study.
Le J; Liao Y; Li S; Chen X; Hong Z
Curr Drug Metab; 2021; 22(6):481-490. PubMed ID: 34455944
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 3A selectively affects the pharmacokinetic interaction between erlotinib and docetaxel in rats.
Qin X; Lu J; Wang P; Xu P; Liu M; Wang X
Biochem Pharmacol; 2017 Nov; 143():129-139. PubMed ID: 28716728
[TBL] [Abstract][Full Text] [Related]
13. Liquid-chromatographic determination of erlotinib (OSI-774), an epidermal growth factor receptor tyrosine kinase inhibitor.
Lepper ER; Swain SM; Tan AR; Figg WD; Sparreboom A
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):181-8. PubMed ID: 14552829
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of bupropion, metroprolol, midazolam, phenacetin, omeprazole and tolbutamide in rat plasma by UPLC-MS/MS and its application to cytochrome P450 activity study in rats.
Ma J; Wang S; Zhang M; Zhang Q; Zhou Y; Lin C; Lin G; Wang X
Biomed Chromatogr; 2015 Aug; 29(8):1203-12. PubMed ID: 25582505
[TBL] [Abstract][Full Text] [Related]
15. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
[TBL] [Abstract][Full Text] [Related]
16. A Drug-Drug Interaction Study to Evaluate the Impact of Simvastatin and Itraconazole on Erlotinib Pharmacokinetics in Rats by UPLC-MS/MS.
Fan Z; Gao X; Wang M; Tian Z
Drug Des Devel Ther; 2023; 17():3129-3138. PubMed ID: 37873519
[TBL] [Abstract][Full Text] [Related]
17. Validated LC-MS/MS method for simultaneous quantification of KRAS
Retmana IA; Loos NHC; Schinkel AH; Beijnen JH; Sparidans RW
J Pharm Biomed Anal; 2023 Oct; 235():115612. PubMed ID: 37557065
[TBL] [Abstract][Full Text] [Related]
18. Development of an LC-MS/MS method for simultaneous determination of ticagrelor and its active metabolite during concomitant treatment with atorvastatin.
Danielak D; Gorzycka P; Kruszyna Ł; Karaźniewicz-Łada M; Główka F
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():113-119. PubMed ID: 30580183
[TBL] [Abstract][Full Text] [Related]
19. Development of a UPLC-MS/MS method for the simultaneous determination of atorvastatin, 2-hydroxy atorvastatin, and naringenin in rat plasma and its application to pharmacokinetic interaction studies.
Li W; Xu X; Wang S; Li Y; Zhang Y; Zhang T
Biomed Chromatogr; 2023 Jan; 37(1):e5515. PubMed ID: 36189913
[TBL] [Abstract][Full Text] [Related]
20. Specific method for determination of OSI-774 and its metabolite OSI-420 in human plasma by using liquid chromatography-tandem mass spectrometry.
Zhao M; He P; Rudek MA; Hidalgo M; Baker SD
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Aug; 793(2):413-20. PubMed ID: 12906916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
